Skip to main content
Neurology

LivaNova’s VNS Therapy Maintains Effectiveness in Drug-Resistant Epilepsy in Latest 2-Year Data

New findings showed that adjunctive VNS therapy led to sustained reductions in generalized tonic-clonic seizure frequency, supporting its long-term efficacy in patients with drug-resistant epilepsy.:

Source: Neurology Read More

Related Posts

Neurology <![CDATA[NeuroVoices: Kate Rosenbluth, PhD, on Expanding Noninvasive Treatment for Essential Tremor With Cala kIQ Plus]]>

<![CDATA[NeuroVoices: Kate Rosenbluth, PhD, on Expanding Noninvasive Treatment for Essential Tremor With Cala kIQ Plus]]>

April 22, 2026
Neurology <![CDATA[Satralizumab Meets Primary End Point in Phase 3 METEOROID Study in MOGAD]]>

<![CDATA[Satralizumab Meets Primary End Point in Phase 3 METEOROID Study in MOGAD]]>

April 21, 2026
Neurology <![CDATA[Up to 8 Years of Ofatumumab Treatment Demonstrates Stable Long-term Safety Profile in Relapsing Multiple Sclerosis]]>

<![CDATA[Up to 8 Years of Ofatumumab Treatment Demonstrates Stable Long-term Safety Profile in Relapsing Multiple Sclerosis]]>

April 21, 2026